Fig. 2
From: Modelling the cost-effectiveness of pay-for-performance in primary care in the UK
Two-way sensitivity analysis showing the optimal strategy for different combinations of the levels of QOF incentive payments and the QOF mortality benefit. The green regions show combinations of values that resulted in an ICER < £30,000/QALY for continuing the QOF compared to stopping the QOF, yellow indicates an ICER of £30,000/QALY and red indicates an ICER of >£30,000/QALY. ICER incremental cost-effectiveness ratio, QALY quality-adjusted life year, QOF Quality and Outcomes Framework